André Hoffmann, the vice chairman and major shareholder of pharmaceutical giant Roche, sees protecting nature as the only ...

About Roche in Neuroscience Neuroscience is a major focus of research and development at Roche. Our goal is to pursue groundbreaking science to develop new treatments that help improve the lives ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the noisy SpaceX creator and X owner. “The arrogance of these guys knows no limit,” grumbles ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence in the country.

For the first time in Canada, a patient has received cancer immunotherapy by subcutaneous (under the skin) injection in their ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulve ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an Innovation Center on Harvard’s Enterprise Research Campus in Allston.

As Roche Canada, we stand ready to work collaboratively to... Simple solutions yield impactful results - all projects selected by jury MISSISSAUGA, ON, Jan. 11, 2024 /CNW/ - Hoffmann-La Roche ...

The Delhi High Court’s March 2025 order allowing Hyderabad-based Natco Pharma to develop a generic version of Risdiplam and rejecting the plea of patent holder Swiss pharma major F Hoffmann-La Roche L ...